Specimens at the same time as it is required to deliver any Definitive Notes pursuant to Clause 4.8 (Delivery of Definitive Notes), specimens of such Notes;
Specimens at the same time as it is required to deliver any Definitive Securities pursuant to Clause 4.7 (Delivery of Definitive Securities) specimens of such Securities; and
Specimens. Upon Nucryst’s request, S&N shall supply to Nucryst or Nucryst’s duly authorized representative, specimens of S&N’s usage of the Nanocrystalline Marks for the purpose of ensuring that S&N is using the Nanocrystalline Marks in accordance with the terms of this Agreement and in a manner approved by Nucryst.
Specimens. Unless otherwise requested by Pfizer, from and after the Effective Date, OPKO (or its designated CRO) will test, store, or manage all biological samples and/or associated slides or blocks (collectively, “Specimens”). *** = Portions of this exhibit have been omitted pursuant to a request for confidential treatment. An unredacted version of this exhibit has been filed separately with the Commission.
Specimens. Unless otherwise requested by Sponsor, CRO shall maintain possession and control of, and will test, store, and manage, all biological samples, tumor samples and tissue samples obtained during the conduct of the Project or the development of a companion diagnostic and any associated slides or blocks (collectively, “Specimens”). Some of the Specimens may be managed and stored at the Sites, as required by the relevant Clinical Project Agreements. Upon Sponsor’s request, CRO shall, or shall request the relevant persons to, promptly ship to Sponsor or its designee all or any portion of the Specimens. In addition, upon Sponsor’s request, CRO shall, or shall request the relevant persons to, provide Sponsor or its designees with reasonable access to and use of the Specimens. CRO will provide the Sponsor with Specimen collection logs upon request. The Parties acknowledge and agree that the relevant informed consents, the Protocol, and the relevant Clinical Project Agreements will need to contain appropriate terms and provisions in order for CRO to be able to comply with, and for Sponsor to be able to receive and use the Specimens in accordance with, the provisions of this Attachment 4 and accordingly, in discussing the form, content, terms and conditions of the relevant informed consents, the Protocol and the relevant Clinical Project Agreements, Sponsor and CRO will work together in good faith to include such appropriate terms and provisions in the relevant informed consents and the Protocol. Sponsor will discuss and adopt principles regarding the collection, storage and management of Specimens in order to give effect to this Attachment 4, such principles to include, among other things, a target number of samples per patient to be provided to Sponsor and its designees, principles relating to interactions with Sites and consortiums that may have access to samples and logistics of handling samples and providing samples to Sponsor and its designees, and such principles shall be commercially reasonable and practicable and consistent with Applicable Laws. The CRO and Sponsor acknowledge that efforts to maintain possession and control of, and the right to test, store, and manage Specimens as set forth in this Attachment 4 may not result in possession and control of Specimens or acquisition of rights with regard to all, substantially all, or even a substantial portion of the Specimens collected in the conduct of the Project.
Specimens. SpeechWorks must submit specimens of all screen shots of the SpeechWorks Integrated Speech Product and other materials (including marketing literature) which include the Slogan, prior to their publication. If AT&T determines that SpeechWorks' use of the Slogan conflicts with or is not expressly permitted by this Agreement, then AT&T shall advise SpeechWorks of same and SpeechWorks shall not distribute the materials to any third party until appropriate corrective action is taken to the satisfaction of AT&T. If AT&T fails to communicate its approval or disapproval of a specimen within [ ] ([ ]) [ ] after receipt, and if SpeechWorks has used Reasonable Efforts to verbally inform AT&T that SpeechWorks did not hear from AT&T during such [ ] ([ ]) [ ] period, and if the specimen does not conflict with these Guidelines, then the specimen shall be deemed approved. Upon approval by AT&T of a specified specimen for a specific purpose, SpeechWorks may make reprints or updated versions of such specimen without AT&T approval, provided that, the format of the Slogan in the specimen has not been changed, modified or otherwise altered. Materials shall not be altered without the prior written approval of AT&T. Such specimens shall be sent in an email containing the subject line "Request for Slogan Approval" to the following address: Name: [ ] AT&T Brand Management 000 X. Xxxxx Xxx. Xxxxxxx Xxxxx, XX 00000 Room [ ] [ ] ([ ]) [ ]-[ ] PRE-APPROVED SPECIMENS Specimens to be mutually agreed within [ ] ([ ]) days of the Effective Date.
Specimens. Should a particular specimen of interest to Owner or FLPC be found on the Property, and Owner or FLPC wishes to acquire such Specimen, an independent valuation will be undertaken, and the greater of the value between the recoverable value of the minerals / metals of the specimen or the independent valuation of specimen, will be used to determine the value of the Specimen. If Owner is acquiring the Specimen, then the incremental value above the metal / mineral value used to calculate the Net Smelter Return will be deducted from Payments owing. If FLPC acquires the specimen, then the incremental value above the metal / mineral value used to calculate the Net Smelter Return will be added to the amount used to calculate the Net Smelter Return. In no event shall either party incur any economic disadvantage by either party acquiring a Specimen. If neither party wishes to acquire a Specimen, and the Specimen is sold by FLPC as such due to it having a greater value, then the incremental value above the metal / mineral value used to calculate the Net Smelter Return will be added to the amount used to calculate the Net Smelter Return. In no event shall Owner incur any economic disadvantage by FLPC selling a Specimen.
Specimens. Each party shall supply such other party with a specimen of each of the party’s uses of the other party’s Marks within fifteen (15) calendar days of a request for a specimen by that other part. In the event that a given use of the other party’s Marks is in software or other product, the specimen shall be that software or product. In the event that a given use of the other party’s Marks is related to a service, the specimen shall be full access to that service.
Specimens. Upon S&N’s request, Nucryst shall supply to S&N or S&N’s duly authorized representative, specimens of Nucryst’s usage of the Licensed Acticoat Marks for the purpose of ensuring that Nucryst is using the Licensed Acticoat Marks in accordance with the terms of this Agreement and in a manner approved by S&N.
Specimens. Licensee agrees to supply MIPS with specimens of Licensee’s uses of the Licensed Marks,’ upon MIPS’ reasonable request in connection with MIPS’ maintenance and protection of Licensed Marks.
